Mesenchymal Stem Cells Decrease Oxidative Stress in the Bowels of Interleukin-10 Knockout Mice
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Background/Aims: Inflammatory bowel disease (IBD) is an autoimmune disease characterized by chronic inflammation mainly in the large intestine. The interleukin-10 knockout (IL-10 KO) mouse is a well-known animal model of IBD that develops spontaneous intestinal inflammation resembling Crohn’s disease. Oxidative stress is considered to be the leading cause of cell and tissue damage. Reactive oxygen species (ROS) can cause direct cell injury and/or indirect cell injury by inducing the secretion of cytokines from damaged cells. This study evaluated the effects of mesenchymal stem cell (MSC) on the progression of IBD. Methods: In this study, human bone marrow-derived MSCs were injected into IL-10 KO mice (MSC). Oxidative stress and inflammation levels were evaluated in the large intestine and compared with those in control IL-10 KO mice (CON) and normal wild-type control mice (Wild). Results: The levels of ROS (superoxide and hydrogen peroxidase) and a secondary end-product of lipid peroxidation (malondialdehyde) were considerably higher in the CON, while superoxide dismutase and catalase levels were lower in the MSC. Inflammation-related marker (interferon-γ, tumor necrosis factor-α, IL-4, and CD8) expression and inflammatory histological changes were much less pronounced in MSC than in CON. Conclusions: MSCs affect the redox balance, leading to the suppression of IBD.
Abstract
Background/Aims: Inflammatory bowel disease (IBD) is an autoimmune disease characterized by chronic inflammation mainly in the large intestine. The interleukin-10 knockout (IL-10 KO) mouse is a well-known animal model of IBD that develops spontaneous intestinal inflammation resembling Crohn’s disease. Oxidative stress is considered to be the leading cause of cell and tissue damage. Reactive oxygen species (ROS) can cause direct cell injury and/or indirect cell injury by inducing the secretion of cytokines from damaged cells. This study evaluated the effects of mesenchymal stem cell (MSC) on the progression of IBD. Methods: In this study, human bone marrow-derived MSCs were injected into IL-10 KO mice (MSC). Oxidative stress and inflammation levels were evaluated in the large intestine and compared with those in control IL-10 KO mice (CON) and normal wild-type control mice (Wild). Results: The levels of ROS (superoxide and hydrogen peroxidase) and a secondary end-product of lipid peroxidation (malondialdehyde) were considerably higher in the CON, while superoxide dismutase and catalase levels were lower in the MSC. Inflammation-related marker (interferon-γ, tumor necrosis factor-α, IL-4, and CD8) expression and inflammatory histological changes were much less pronounced in MSC than in CON. Conclusions: MSCs affect the redox balance, leading to the suppression of IBD.
참고문헌 (27)
- Sheehan D, "The gut microbiota in inflammatory bowel disease", Gastroenterol Clin North Am, 46, pp.143~154 (2017)
- de Lange KM, "Understanding inflammatory bowel disease via immunogenetics", J Autoimmun, 64, pp.91~100 (2015)
- Singh UP, "CXCL10-producing mucosal CD4+ T cells, NK cells, and NKT cells are associated with chronic colitis in IL-10(-", -)mice, which can be abrogated by anti-CXCL10 antibody inhibition, 2008, pp.28, 31~43
- Sheehan D, "The microbiota in inflammatory bowel disease", J Gastroenterol, 50, pp.495~507 (2015)
- Randall-Demllo S, "Intestinal epithelium and autophagy : partners in gut homeostasis", Front Immunol, 4, pp.301~ (2013)
- Pott J, "Epithelial autophagy controls chronic colitis by reducing TNF-induced apoptosis", Autophagy, 14, pp.1460~1461 (2018)
- Sturm A, "Epithelial restitution and wound healing in inflammatory bowel disease", World J Gastroenterol, 14, pp.348~353 (2008)
- van der Gracht E, "When insult is added to injury : cross talk between ILCs and intestinal epithelium in IBD", Mediators Inflamm, 2016, pp.9765238~ (2016)
- Zhernakova A, "Detecting shared pathogenesis from the shared genetics of immune-related diseases", Nat Rev Genet, 10, pp.43~55 (2009)
- Smids C, "Intestinal T cell profiling in inflammatory bowel disease : linking T cell subsets to disease activity and disease course", J Crohns Colitis, 12, pp.465~475 (2018)
- Chakrabarti S, "Food-derived bioactive peptides on inflammation and oxidative stress", Biomed Res Int, 2014, pp.608979~ (2014)
- Caplan AI, "New MSC : MSCs as pericytes are Sentinels and gatekeepers", J Orthop Res, 35, pp.1151~1159 (2017)
- Zhao S, "Immunomodulatory properties of mesenchymal stromal cells and their therapeutic consequences for immune-mediated disorders", Stem Cells Dev, 19, pp.607~614 (2010)
- Nakagome K, "In vivo IL-10 gene delivery suppresses airway eosinophilia and hyperreactivity by downregulating APC functions and migration without impairing the antigen-specific systemic immune response in a mouse model of allergic airway inflammation", J Immunol, 174, pp.6955~6966 (2005)
- Song IH, "Simple evaluation method for osteoinductive capacity of cells or scaffolds using ceramic cubes", Tissue Cell, 46, pp.372~378 (2014)
- Nourooz-Zadeh J, "Ferrous ion oxidation in presence of xylenol orange for detection of lipid hydroperoxides in plasma", Methods Enzymol, 300, pp.58~62 (1999)
- Song IH, "Mesenchymal stem cells attenuate adriamycin-induced nephropathy by diminishing oxidative stress and inflammation via downregulation of the NF-kappaB", Nephrology(Carlton), 23, pp.483~492 (2018)
- Baumgart DC, "Inflammatory bowel disease : cause and immunobiology", Lancet, 369, pp.1627~1640 (2007)
- 송인환, "임상적용을 위한 세포치료제로서의 성체 중간엽줄기세포", Journal of Yeungnam Medical Science, 26(1), pp.1~14 (2009), 영남대학교 의과대학
- Caplan AI, "Mesenchymal stem cells: time to change the name!", Stem Cells Transl Med, 6, pp.1445~1451 (2017)
- Nagaishi K, "Stem cell therapy for inflammatory bowel disease", J Gastroenterol, 50, pp.280~286 (2015)
- Jung WY, "Human adipose-derived stem cells attenuate inflammatory bowel disease in IL-10 knockout mice", Tissue Cell, 47, pp.86~93 (2015)
- Montalvo-Javé EE, "Piroxicam and meloxicam ameliorate hepatic oxidative stress and protein carbonylation in Kupffer and sinusoidal endothelial cells promoted by ischemia-reperfusion injury", Transpl Int, 24, pp.489~500 (2011)
- Weber C, "IBD : Lactococcus lactis alleviates oxidative stress and colitis in mice", Nat Rev Gastroenterol Hepatol, 12, pp.429~ (2015)
- Halliwell B, "Role of free radicals and catalytic metal ions in human disease : an overview", Methods Enzymol, 186, pp.1~85 (1990)
- Jomova K, "Advances in metal-induced oxidative stress and human disease", Toxicology, 283, pp.65~87 (2011)
- Piechota-Polanczyk A, "Review article : the role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases", Naunyn Schmiedebergs Arch Pharmacol, 387, pp.605~620 (2014)